Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study - Quiz - MDSpire

Aripiprazole as second-line pharmacotherapy for a heterogeneous cohort of refractory functional dizziness disorders: a pilot preliminary retrospective study

  • By

  • Fumiyuki Goto

  • Koichiro Wasano

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Related Content